3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Urinary Tract Infections
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Infections
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Herpes Simplex
1
Hemophilia A
1
Hemangioma, Capillary
1
Heart Failure
1
Heart Arrest
1
Interventions
Filgrastim
7
pegylated granulocyte colony-stimulating factor
5
pegfilgrastim
5
Cytarabine
4
Ciprofloxacin
4
Cefepime
4
Vancomycin
3
Leucovorin
3
Fluorouracil
3
Amikacin
3
trifluridine tipiracil drug combination
2
Piperacillin, Tazobactam Drug Combination
2
Methylprednisolone
2
Meropenem
2
Irinotecan
2
Etoposide
2
Daptomycin
2
Cisplatin
2
Ceftazidime
2
ziprasidone
1
trilaciclib
1
sargramostim
1
niraparib
1
liposomal amphotericin B
1
lintuzumab
1
leridistim
1
isavuconazole
1
fludarabine phosphate
1
flt3 ligand protein
1
fish oil triglycerides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neutropenia
×
Lurasidone Hydrochloride
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled